33 First Line Therapy for HER2- PDL1+ GEA

34 First Line Therapy for HER2- PDL1- CLDN18.2+ GEAПодробнее

35 First Line Therapy for HER2-, PDL1-, CLDN18.2- GEAПодробнее

32 First Line Therapy for HER2+ GEAПодробнее

Transforming HER2-Positive Breast Cancer Treatment: T-DXd’s Potential as First-Line TherapiesПодробнее

Protocols for HER2-Expressing GI Cancers: Refining BTC and GEA Care With Targeted AgentsПодробнее

Zanidatamab + chemo as 1L therapy in HER2-expressing GEAПодробнее

MAHOGANY: margetuximab and retifanlimab in HER2+, 1L unresectable/metastatic GEAПодробнее

Phase III trial of first-line SHR-1701 with chemotherapy in HER2- G/GEJAПодробнее

Updates in treatments for HER2-positive GEAПодробнее

First-Line Treatment of HER2-Positive Metastatic Breast CancerПодробнее

Updates in the management of HER2 positive Breast CancerПодробнее

Changing Treatment Landscape In HR+HER2 aBCПодробнее

New Breast Cancer Drug Shows Remarkable Results for HER2-Positive Patients. #science #cancerПодробнее

First line immunotherapy/chemotherapy in HER2- gastric cancer in JapanПодробнее

What Is the Current Standard for First-Line Treatment of Metastatic HER2-Negative G/GEJ Cancers?Подробнее

Breaking Barriers: KEYTRUDA Triumphs as First-Line Treatment for HER2-Positive Gastric CancerПодробнее

HER2 & PD-L1: Exploring Clinical Characteristics of G/GEJ Cancers in Relation to Biomarker Positi...Подробнее

How is HER2 positive breast cancer treated? #shortsПодробнее

Personalized treatment of advanced HER2-negative gastric or gastroesophageal junction cancerПодробнее